- Changes in Skeletal Tumor Activity on 18F-choline PET/CT in Patients Receiving 223Radium Radionuclide Therapy for Metastatic Prostate Cancer
-
Miyazaki K, Kuang Y, Kwee SA
- KMID: 2313265
- Nucl Med Mol Imaging.
- 2015 Jun;49(2):160-164.
- doi: 10.1007/s13139-014-0314-0
Radium-223 dichloride is an alpha-emitting radiopharmaceutical shown to prolong survival in patients with castrate-resistant prostate cancer (CRPC) and symptomatic skeletal metastases. This report describes in two patients the acute changes... -
- CITED
-
- Close
- SHARE
-
- Close
- Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
-
Wong LL, Reyes RJ, Kwee SA, Hernandez , Kalathil S, Tsai NC
- KMID: 2400671
- Clin Mol Hepatol.
- 2017 Sep;23(3):239-248.
- doi: 10.3350/cmh.2017.0008
BACKGROUND/AIMS: Surveillance for hepatocellular carcinoma (HCC) with ultrasound in high-risk populations is generally believed to improve opportunities for treatment. However, tumors are still missed due to various factors. This study... -
- CITED
-
- Close
- SHARE
-
- Close
